Mental health startup focused on seniors launches with $32M, backing from Arch Venture Partners The news: Rippl, a Seattle startup focused on the mental health of seniors, launched Wednesday with $32 million in seed… Read More
ARCH Venture Partners raises close to $3B for early-stage biotech fund ARCH Venture Partners has closed a $2.975 billion fund targeted for early-stage biotech companies. The firm’s 12th venture fund comes… Read More
Juno’s lasting legacy: How the cell therapy juggernaut influenced biotech in Seattle and beyond When Juno Therapeutics launched in 2013, cell therapy was a nascent field. Early clinical studies were showing dramatic rates of… Read More
Seattle biotech investor Robert Nelsen named to Midas List of top performing VCs, propelled by early investment in Juno Robert Nelsen may not be a household name in venture capital circles — certainly not the way that Reid Hoffman,… Read More
